source
- Smith & Nephew lowers 2026 sales outlook as US knee implant revenue falls 7%Smith & Nephew announced a revision to its 2026 sales outlook, now expecting underlying revenue growth of about 4% versus the prior 6% target. The change follows a second‑quarter report showing re…
- Bayer plans German launch of new stroke drug despite healthcare spending cutsBayer announced it will move forward with the launch of its new stroke medication in Germany. The decision comes even though Germany has introduced a new healthcare spending bill that reduces reim…